1mg, best e pharmacy in India


Rs.9240.70for 1 vial(s) (1 ML injection each)
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR CUROSURF

Poractant Alfa(120 mg)

food interaction for CUROSURF

alcohol interaction for CUROSURF

pregnancy interaction for CUROSURF

lactation interaction for CUROSURF

It can be taken with or without food, but it is better to take Curosurf 120mg injection at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.


Poractant Alfa(120 mg)


Curosurf 120mg injection is used for respiratory distress syndrome (immature lungs in preterm baby )

How it works

Curosurf 120mg injection is the surfactant given to premature babies to protect their lungs. The surfactant is a fatty substance that coats the inside or lining of the air sacs in the lungs. This coating prevents the air sacs from collapsing and sticking together when air leaves the lungs. The surfactant is produced by babies only after the 8th month of pregnancy.

Common side effects

Pnemothorax (accumulation of air or gas in the chest or pleural space), Brain haemorrhage, Chronic lung disease, Decreased oxygen level in blood, Infection


No substitutes found

Expert advice FOR CUROSURF

  • Before starting poractant alfa treatment, infants should be treated for anemia, low blood pressure, chills, low blood sugar levels, acidosis.
  • Tell the doctor or dentist that your child takes poractant alfa before your child receives any medical or dental care, emergency care, or surgery.
  • Your child should be closely monitored for any signs of infection while receiving poractant alfa treatment.

Frequently asked questions FOR CUROSURF

Poractant Alfa

Q. What is poractant alfa?
Poractant alfa is a natural lung surfactant that lubricates the linings of the air spaces in lungs and prevents them from sticking together. It is effective in babies who have difficulty in breathing due to lack of enough surfactant in their lungs.


Content on this page was last updated on 12 January, 2017, by Dr. Varun Gupta (MD Pharmacology)